| pubmed-article:18077948 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0001962 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0015075 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0752156 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0695347 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0032624 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C1332335 | lld:lifeskim |
| pubmed-article:18077948 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:18077948 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:18077948 | pubmed:dateCreated | 2007-12-14 | lld:pubmed |
| pubmed-article:18077948 | pubmed:abstractText | A dural arteriovenous fistula (DAVF) typically involves meningeal feeding arteries and can cause clinical symptoms ranging from tinnitus to rupture of draining cortical or parenchymal veins. Surgical treatment may be technically demanding. Ethylene vinyl alcohol (Onyx, ev3 Neurovascular) has several properties that make it potentially useful as a primary treatment agent for DAVF. Onyx is expected to be a permanent embolic agent. It should have a decreased risk of catheter retention when compared with other permanent embolic materials. | lld:pubmed |
| pubmed-article:18077948 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18077948 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077948 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:18077948 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077948 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18077948 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18077948 | pubmed:issn | 0022-3085 | lld:pubmed |
| pubmed-article:18077948 | pubmed:author | pubmed-author:TaylorChristo... | lld:pubmed |
| pubmed-article:18077948 | pubmed:author | pubmed-author:YonasHowardH | lld:pubmed |
| pubmed-article:18077948 | pubmed:author | pubmed-author:CarlsonAndrew... | lld:pubmed |
| pubmed-article:18077948 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18077948 | pubmed:volume | 107 | lld:pubmed |
| pubmed-article:18077948 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18077948 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18077948 | pubmed:pagination | 1120-5 | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:meshHeading | pubmed-meshheading:18077948... | lld:pubmed |
| pubmed-article:18077948 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:18077948 | pubmed:articleTitle | Treatment of dural arteriovenous fistula using ethylene vinyl alcohol (onyx) arterial embolization as the primary modality: short-term results. | lld:pubmed |
| pubmed-article:18077948 | pubmed:affiliation | Department of Neurosurgery, University of New Mexico, Albuquerque, New Mexico 87131-0001, USA. | lld:pubmed |
| pubmed-article:18077948 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18077948 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077948 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077948 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077948 | lld:pubmed |
